Clinical Trials are essential in the development of new cancer treatments.
In a very small number of patients with a strong family history of pancreatic cancer (two or more close relatives affected), screening using endoscopic ultrasound (EUS) surveillance may be considered. The true value of screening is unknown and is performed as part of research studies. Research has shown that early detection and treatment on pancreatic cancer greatly improves survival rates.
A screening trial at Austin Health is currently underway. This trial combines the work of the departments of Surgery, Gastroenterology, Genetics and the Olivia Newton John Cancer Centre at Austin Health in collaboration with Sydney’s St Vincent’s Hospital and the Garvan Institute of Medical Research. The aim of the study is to identify and screen high-risk individuals using EUS, a diagnostic test to detect small changes to the pancreas.
The Australian Government, National Health and Medical Research Council has created some informative videos about the importance of clinical trials, you can find more information through their website.